| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 821.50 | 0.6% | 6.6% |
| Total Income | 821.50 | 0.6% | 6.6% |
| Expenditure | 715.80 | 0.2% | 0.9% |
| PBT | — | ||
| Net Profit | -22.70 | 808.0% | 28.4% |
| OPM | 12.87% | 0.65pp | 4.96pp |
| NPM | -2.76% | 2.46pp | 1.35pp |
| EPS | -0.18 | 800.0% | 28.0% |
Surgery Partners Reports Results for Nine Months Ended September 30, 2025
04 May 2026 · 4 May, 7:30 am
Summary
The press release announces the results for the three and nine months ended September 30, 2025. Surgery Partners makes reference to non-GAAP financial measures and provides a reconciliation of such measures to GAAP.
Informational and educational content only. Not investment advice.